As 2024 draws to a close, we at the Foundation for Prader-Willi Research (FPWR) are reflecting on a year filled with progress, promise, and hope. This year’s achievements wouldn’t have been possible without the incredible dedication of our community—researchers, families, donors, and advocates—who...
Source: FPWR Blog
|
Published: December 12 2024 - 09:30 AM
The PWS-Clinical Investigation Collaborative (PWS-CLIC), a network of PWS clinical experts formally established in 2021 and supported by FPWR, held their annual meeting in Atlanta, Georgia, in conjunction with the FPWR Research Symposium and Family Conference, on September 27th, 2024. We had 15...
Source: FPWR Blog
|
Published: November 11 2024 - 09:00 AM
The Foundation for Prader-Willi Research (FPWR) employs a "de-risking" funding strategy to accelerate the development of new treatments for Prader-Willi syndrome (PWS). We are here to take the risks, fund new ideas, and help build the resources that will advance treatments to the finish line.
Source: FPWR Blog
|
Published: November 11 2024 - 07:34 AM
We are pleased to announce the recipients of our second round of grants for 2024, totaling $1,681,781 in awards, as part of the Foundation for Prader-Willi Research’s (FPWR) ongoing commitment to advancing research in Prader-Willi syndrome (PWS) and Schaaf-Yang syndrome (SYS). These grants will...
Source: FPWR Blog
|
Published: November 11 2024 - 06:30 AM
Although rare overall, people with PWS have a higher risk for developing dangerous blood clots than the general population. A blood clot is a mass of blood that has changed from its liquid state into a semi-solid or gel-like form.
Source: FPWR Blog
|
Published: November 11 2024 - 09:00 AM
